top of page

Search Results

Results found for "Dr. Tim De Groof"

  • Your GPCR Program Decisions Depend on Good Data Interpretation

    That’s why this week at Dr. delays key milestones. 🗣️ “Thank you for bringing this (Principles of Pharmacology I) course with Dr I wish Dr. Ingo Hartung : State-of-the-art design of small molecule drugs, including PROTACs Dr. Get The Full Story ➤ Why Dr. GPCR Premium Membership Gives You an Edge Dr.

  • The Truth About GPCR Product Launches: Years in the Making

    Featuring logos from Dr. GPCR and Revvity. In this behind-the-scenes look at the making of Revity’s pHSense, Dr. Dr. Want to hear Dr. Trinquet tell the story in his own words? GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr.

  • đź“° GPCR Weekly News, October 16 to 22, 2023

    This week's highlights: Dr. Norton Cheng and Dr. Dr. Thomas P. Our confirmed speakers are Dr. Xavier Leroy, Dr. Brian Arey, and Dr. J. Silvio Gutkind. Subscribe to Dr. GPCR Newsletter for more insights!

  • GPCR Selectivity Beyond the Receptor — Live April 9th with Bryan Roth

    Bryan Roth joins the Dr. Explore the Dr. Explore the Dr. Sign up to get access ➤ Dr. Explore the library ➤ What Members Say The Dr.

  • Signals in Motion: Pain, Metabolism & Terry’s Corner

    Hello GPCR Innovators ,   We’re preparing to launch Terry’s Corner, a new knowledge hub shaped by Dr. Plus, Celtarys explores ligand selection for better assays, and co-founder Dr. pain relief in preclinical models Dr.GPCR Updates Terry’s Corner  – Build Better GPCR Screens with Dr Screening Strategy Leadership in Ligand Design  – The Celtarys Origin Story   In  this founder interview , Dr Best,   The Dr. GPCR Team

  • How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights

    Week’s GPCR Intelligence: From Set-Point Pharmacology to No-Wash Internalization Assays This week’s Dr Unlock On-Demand Yearly Access Now — Premium Members Get Over 50% Discount at Checkout ➤ Revvity x Dr GPCR: A Mission-Aligned Partnership That Advances the Field At Dr. As Dr. Eric Trinquet shares in a special Dr. I will keep Dr.

  • Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?

    At Dr. GPCR, we recognized this core problem. This is the essence of de-risking GPCR programs through operational excellence. your drug discovery process from a series of disconnected efforts into a seamless, predictable, and de-risked Learn to translate your program’s internal operational precision into a compelling, de-risked narrative

  • Better GPCR Drug Discovery Decisions Start With Structured Learning

    Dr. GPCR University — Reorganized for Clarity and Speed The Dr. In this session, Dr. An upcoming live Ask-Me-Anything (AMA) with Dr. Kenakin takes place February 26 at 12:00 PM EST. Submit your work today ➤ Why Dr. classified publications, priority event tracking, curated career opportunities, and full access to Dr

  • Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today

    When PK is misunderstood early, Dr. derail programs Every therapeutic area—CNS, cardiovascular, GI—faces the same core PK constraints Dr Across therapeutic classes, Dr. small molecules, but protein binding, transporters, and tissue architecture  play decisive roles Dr Why Terry’s Corner Terry’s Corner  delivers weekly pharmacology lectures from Dr.

  • How Schild Analysis Protects Your Conclusions in GPCR Research

    In this week’s lesson, Dr. Access this week’s key insight ➤ Dr. Dr. 👉 Access this week’s full Premium Edition here ➤ What Members Say “Dr. See you in the Ecosystem, Dr. GPCR Team

  • Assay Volume Control: Your GPCR Drug Discovery Power Lever

    . 🔍 This Week in Dr. In this upcoming episode, Dr. In this behind-the-scenes look, Dr. Read the full story➤ Why Dr. I wish Dr.

  • How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program

    This week Dr. In this week's Dr. Dr. “The best pharmacology teacher (Dr. Dr.

  • Irreversible Drugs, Real Control: Design for Durable Target Engagement

    This week’s Dr. Emerging Voices in GPCR Biology; Domain Therapeutics patents new PAR2 antagonists. 🔍 This Week in Dr 🎥  Live AMA with Dr. Kenakin — October 30, 12 PM EST   Join Dr. say in the topics covered next Weekly updates that keep your knowledge sharp Monthly live AMAs with Dr Listen to the episode ➤ Why Dr.

  • 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024

    Dr. GPCR Kicked Off as a Podcast... go for a Premium Membership , you'll not only back our mission but also snag fantastic perks like: Dr Direct line to the Dr. Jude Children's Research Hospital Welcomes Dr. GPCR drugmaker Septerna amasses $288M in IPO Surrounded by AI bio giants, tiny startup Nabla Bio makes de

  • GPCR Collaboration: From Models to Medicine

    But Carlsson doesn’t try to do everything under one roof. Carlsson’s lab is a proof point : collaboration is not just a cultural preference. Want to hear how Dr. Carlsson mentors the next generation? 🎧 Listen to the full episode on the Dr. GPCR Podcast 🌱 Build a career with purpose, not just papers The Dr.

  • From Farm Fields to GPCR Discovery, GLP-1 and GIP

    Enter a long-term collaboration with chemist Dr. Emerging direction: Treatment sequencing + guided de-escalation. this story resonates with your work or curiosity, go deeper. 🎧 Listen to the full conversation with Dr

  • Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology

    This week in Terry’s Corner, Dr. DR curves shift to the right with no loss of maximal effect. Each subscription includes: Weekly deep dives from Dr. But Terry cautions: “These patterns are consistent with, but not proof of, mechanism.

  • GPCR Selectivity Beyond the Receptor

    So is Dr. Terry Hébert. Dr. Kenakin is a leading expert in the field. Aside from his vast experience in drug development, not to mention his extensive publication record, Dr Kenakin is a masterful teacher and communicator. — Dr. GPCR Course Attendee About Dr. GPCR Dr.

  • How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs

    Dr. Frame your strategy, then let the serendipity occur.” — Dr. Want to hear Dr. Trinquet tell the story in his own words? Listen to the full podcast episode here ⸻ More about Revvity pHSense Reagents GPCR Reagents Revvity on Dr GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr.

  • đź“° GPCR Weekly News, April 29 to May 5, 2024

    Today, we celebrate a huge milestone by releasing Episode #150 of the Dr. GPCR Podcast. ’s episode, so join us in this celebration and be the first to know about all the changes coming to Dr Today is also the first session of our hands-on workshop with Dr. Sam Hoare. If you aren't joining us this time, stay tuned for more Dr. GPCR University content coming soon.

  • How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision

    . 🔍 This Week in Dr. This week, Dr. Premium Members get a 50%+ discount when they join Terry’s Corner. 🚨 First-ever Live AMA with Dr. Unlock Terry’s Corner ➤ Dr. GPCR Podcast – Ajay Yekkirala on GPCR Innovation In this episode, Dr. Register now to secure your spot ➤ Why Dr.

  • đź“° GPCR Weekly News, May 6 to 12, 2024

    This week's highlight includes congrats to: Drs. Dr. GPCR Podcast Episode #151 is out! A special episode with our board, meet Drs. Did you watch Episode #150 of the Dr. GPCR Podcast? Dr. Dr.

  • GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions

    Stop Chasing Affinity and Start Reading the System In this week’s cornerstone Terry’s Corner lecture, Dr As the GPCR field surges forward—from ligand bias to signaling diversity—the guest editors Dr. squarely on kinetic modeling, allosteric frameworks, and targeting the “undruggable.” 🔥 Featured:  Dr ” — Dr. GPCR Podcast Listener Why Dr. FAQ: What You Get with Dr. GPCR Premium 🔹 What’s included?

  • đź“° GPCR Weekly News, April 1 to 7, 2024

    Dr. GPCR University Hurry! 3 out of the 25 spots have been filled! Join our upcoming Dr. GPCR University hands-on workshop with Dr.  The workshop includes: Four x 2-hour Zoom sessions One-on-one meeting with Dr. Hoare Access to Dr. Dr. Dr.

  • đź“° GPCR Weekly News, January 8 to 14, 2024

    This week's highlight: Dr. Dr. GPCR University February 8 - 29: Join Dr. GPCR University's live course with Dr. Terry Kenakin. GPCR Ecosystem group, where you can find Dr. Kenakin and Dr. GPCR Complimentary one-year Dr. Go to Dr. GPCR University and save your spot today! Dr.

  • Why Kinetics Matter More Than Kd in GPCR Drug Discovery

    Kenakin is a masterful teacher and communicator—and a leading expert in our field.” — Dr. GPCR University Course Attendee Dr. GPCR Podcast : From Personal Pain to Scientific Purpose: Alex Serafini’s Journey We sit down with Dr. Secure your spot ➤ Why Dr. Dr.

  • đź“° GPCR Weekly News, January 15 to 21, 2024

    This week's highlight: Dr.  Dr. GPCR University Our first Dr. Kenakin Access to the cohort’s Dr. Kenakin and Dr. GPCR Complimentary one-year Dr. Dr.

  • đź“° GPCR Weekly News, March 25 to March 31, 2024

    GPCR University Get ready for our next Dr. GPCR University hands-on workshop with Dr.  GPCR Ecosystem group, where you can find Dr. Hoare and Dr. GPCR Complementary one-year Dr. Dr. GPCR Symposia With a premium membership, you can watch on-demand the Dr. Dr.

bottom of page